Reconcilable defferences: A cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting β-agonist use in asthma

Chest

Volumn 126, Issue 4, 2004, Pages 1161-1168

  Lynd, Larry D ^a   Sandford, Andrew J ^b   Kelly, Erin M ^b   Paré, Peter D ^b   Bai, Tony R ^b   FitzGerald, J Mark ^c   Anis, Aslam H ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b iCAPTURE Centre   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d Ctr Hlth Eval and Outcome Sci   (Canada)

Author keywords

Adrenergic agonists; Asthma; Severity of illness index; Social class

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CANADA; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; SOCIAL CLASS; STATISTICAL MODEL;

ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS;

EID: 6344291534     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.4.1161     Document Type: Article

References (42)

1. Friday GA, Khine H, Ling LS, et al. Profile of children requiring emergency treatment for asthma. Ann Allergy Asthma Immunol 1997; 78:221-224
2. Griffiths C, Naish J, Sturdy P, et al. Prescribing and hospital admission for asthma in east London. BMJ 1996; 312:481-482
3. Spitzer W, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326:501-506
4. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336:1391-1396
5. Van Ganse E, van der Linden PD, Leufkens HG, et al. Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. Eur Respir J 1995; 8:1856-1860
6. Taylor D, Sears M, Herbison G, et al. Regular inhaled β-agonist in asthma: effects on exacerbations and lung function. Thorax 1993; 48:134-138
7. van Schayck CP, Dompeling E, van Herwaarden Gees L, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomized controlled study. BMJ 1991; 303:1426-1430
8. Boulet L-P, Becker A, Bérubé D, et al. Canadian asthma consensus report, 1999. Can Med Assoc J 1999; 161(11 Suppl):S1-S62
9. Lynd LD, Guh DP, Pare PD, et al. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002; 122:1973-1981
10. Anis A, Lynd L, Wang X, et al. Double trouble: inappropriate asthma medication use linked to increased use of health care resources. Can Med Assoc J 2001; 164:625-631
11. Watson J, Cowen P, Lewis R. The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur Respir J 1996; 9:2087-2093
12. Chen Y, Dales R, Krewski D. Asthma and the risk of hospitalization in Canada: the role of socioeconomic and demographic factors. Chest 2001; 119:708-713
13. Erzen D, Carriere K, Dik N, et al. Income level and asthma prevalence and care patterns. Am J Respir Crit Care Med 1997; 155:1060-1065
14. Boulet LP, Belanger M, Lajoie P. Characteristics of subjects with a high frequency of emergency visits for asthma. Am J Emerg Med 1996; 14:623-628
15. Higgins B, Britton J. Geographical and social class effects on asthma mortality in England and Wales. Respir Med 1995; 89:341-346
16. Littlejohns P, Macdonald LD. The relationship between severe asthma and social class. Respir Med 1993; 87:139-143
17. Lynd LD, Warren LD, Maclure M, et al. Using administrative healthcare data to recruit study subjects: experience with "camouflaged sampling." Eur J Epidemiol 2004; 19:517-525
18. American Thoracic Society. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:1285-1298
19. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
20. Cotton C, Webber M, Saint-Pierre Y. Should low income cutoffs be updated? A discussion paper. Ottawa: Income Statistics Division, Statistics Canada, 1999, Report No. 75F0002MIE-99009
21. BC Stats. Census of Canada. Victoria, BC: Ministry of Finance and Corporate Relations, 1998
22. 2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158:787-791
23. Bailey WC, Higgins DM, Richards BM, et al. Asthma severity: a factor analytic investigation. Am J Med 1992; 93:263-269
24. The Joint Task Force on Practice Parameters. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995; 96:707-870
25. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996; 98:1016-1018
26. Juniper E, Guyatt G, Epstein R. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47:76-83
27. Wahlgren DR, Hovell MF, Matt GE, et al. Toward a simplified measure of asthma severity for applied research. J Asthma 1997; 34:291-303
28. Selim AJ, Ren XS, Fincke G, et al. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest 1997; 111:1607-1614
29. Ng TP. Validity of symptom and clinical measures of asthma severity for primary outpatient assessment of adult asthma. Br J Gen Pract 2000; 50:7-12
30. Stokes M, Davies C, Koch G. Categorical data analysis using the SAS system. Cary, NC: SAS Institute, 1995
31. Mielck A, Reitmeir P, Wjst M. Severity of childhood asthma by socioeconomic status. Int J Epidemiol 1996; 25:388-393
32. Persky VW, Slezak J, Contreras A, et al. Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children. Ann Allergy Asthma Immunol 1998; 81:266-271
33. Strachan DP, Anderson HR, Limb ES, et al. A national survey of asthma prevalence, severity, and treatment in Great Britain. Arch Dis Child 1994; 70:174-178
34. Connolly CK, Chan NS, Prescott RJ. The influence of social factors on the control of asthma. Postgrad Med J 1989; 65:282-285
35. 2-Agonist metered dose inhaler overuse: psychological and demographic profiles. Pediatrics 1997; 99:40-43
36. Togias A, Horowitz E, Joyner D, et al. Evaluating the factors that relate to asthma severity in adolescents. Int Arch Allergy Immunol 1997; 113:87-95
37. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Biol 1993; 8:334-339
38. Green S, Turki J, Innis M, et al. Amino-terminal polymorphins of the human β-adrenergic receptor impart distinct agonist promoted regulatory properties. Biochemistry 1994; 33:9414-9419
39. Hall I, Wheatley A, Wilding P, et al. Association of GLY 27 β-receptor polymorphism svith lower airway reactivity in asthmatic subjects. Lancet 1995; 345:1213-1214
40. Turki J, Pak J, Green S, et al. Genetic polymorhpisms of the β-adrenergic receptor in nocturnal and non-nocturnal asthma. J Clin Invest 1995; 95:1635-1641
41. Gochman DS. Health behavior: emerging research perspectives. New York, NY: Plenum Press, 1988
42. Jumper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907